These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.
Tryngolza: Package Insert / Prescribing Information / MOA
Feb 9, 2025 · Tryngolza package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
First FDA-Approved Medicine for FCS | TRYNGOLZA®
TRYNGOLZA® (olezarsen) is an FDA-approved treatment in adults with FCS as an adjunct to diet. See Safety & Full Prescribing Information.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA. …
Tryngolza Injection, Solution FDA Label - NDC 71860-101
4 days ago · FDA Structured Product Label (SPL) for Tryngolza (NDC 71860-101). Review professional prescribing information, including 1 indications and usage, 2.1
Tryngolza | European Medicines Agency (EMA)
Jul 25, 2025 · Tryngolza can only be obtained with a prescription and is available as a solution for injection in prefilled pens. It is injected once a month under the skin in the abdomen (belly), the front …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA® safely and effectively. See full prescribing information for TRYNGOLZA.
TRYNGOLZA Prescription & Dosage Information - MPR
TRYNGOLZA prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and TRYNGOLZAside effects.
FDA-approved Indications1 Tryngolza is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
FDA-Approved Therapy for FCS | TRYNGOLZA® (olezarsen)
ADVERSE REACTIONS Most common adverse reactions (incidence >5% of TRYNGOLZA-treated patients and >3% higher frequency than placebo) were injection site reactions, decreased platelet …